AKT1 and Familial prostate cancer: Interestingly, pre-treatment of prostate cancer cells with pictilisib (a PI3K-specific inhibitor) or MK-2206 (a p-Akt-specific inhibitor) reversed this decrease in Akt protein expression (Figure 3E).